Regeneron Pharmaceuticals Inc (REGN)
Days of sales outstanding (DSO)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 2.51 | 2.53 | 2.53 | 2.29 | 2.27 | 2.36 | 2.51 | 2.31 | 2.35 | 2.47 | 2.42 | 2.28 | 2.47 | 2.76 | 3.41 | 2.66 | 2.48 | 1.77 | 2.20 | 2.07 | |
| DSO | days | 145.69 | 144.06 | 144.10 | 159.65 | 160.98 | 154.70 | 145.50 | 157.70 | 155.63 | 147.53 | 151.04 | 159.78 | 147.71 | 132.42 | 106.99 | 137.09 | 146.94 | 206.27 | 165.60 | 176.75 |
September 30, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 2.51
= 145.69
Peer comparison
Sep 30, 2025
Company name
Symbol
DSO
Regeneron Pharmaceuticals Inc
REGN
145.69
Arrowhead Pharmaceuticals Inc
ARWR
3.00
Biomarin Pharmaceutical Inc
BMRN
93.23
See also:
Regeneron Pharmaceuticals Inc Average Receivable Collection Period (Quarterly Data)